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1. Introduction
Animals that possess regenerative abilities are widespread in the animal kingdom [1]. Hydra,
planarian, zebrafish, newt and axolotl are known prominent species, and the cellular aspects
of the stem cell system for regeneration are well elucidated [2]. However, few animals can be
used to investigate the molecular basis of neuronal regeneration, in spite of the presence of
prominent regenerative animals, as mentioned above. Planarians, for instance, can regenerate
a functional brain after amputation in a few days, even from non-brain tissue [3,4]. Newts can
regenerate several tissues and organs (i.e., lens, limbs, jaws, hearts and tails) with recovery of
function and physiology after injury or tissue removal [5-8]. These animals achieve regenera‐
tion of missing nervous system utilizing stem cells. However, it is difficult to regenerate
nervous system in mammalians, including human beings, although these animals possess
neural stem cells. Therefore, regenerative animals provide unique opportunities to investigate
the generation and utilization of stem cells to repair lost or injured tissue in non-regenerative
animals. On the other hand, the successful derivation of neural cells from human embryonic
stem cells (ESCs) [9] and induced pluripotent stem cells (iPSCs) [10,11] under in vitro conditions
provides a new experimental strategy for clinical translation. In other words, although human
beings lack regenerative abilities, the new clinical strategy of “regenerative medicine,”
including cell-transplantation therapy, has been developed to recover lost neural functions by
using stem cells. This research field has become a greatly advancing scientific field worldwide.
© 2013 Nishimura et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In this chapter, we focus on the molecular systems of generation of functional dopaminergic
(DA) neurons in vivo and/or in vitro in regenerative and non-regenerative animals. The first
topic investigates how regenerative animals recruit new DA neurons from stem cells after
injury. The second topic explores how to generate DA neurons from mammalian ESCs and
iPSCs under in vitro conditions. The third topic evaluates clinical applications for human neural
disease, especially Parkinson’s disease.
2. DA neuronal regeneration in regenerative animals
Freshwater planarians, Plathelminthes, have a primitive central nervous system (CNS) that is
composed of a well-organized brain and a pair of ventral nerve cords [12]. Large-scale
expression analyses have revealed that many neural genes involved in vertebrate brain
development and function are also expressed in distinct domains of the planarian CNS [13,14].
These results indicate that the planarian CNS is functionally regionalized according to a
discrete expression of neural-specific genes.
We recently discovered that the planarian CNS contains dopamine, serotonin, γ-aminobutyric
acid (GABA) and acetylcholine, which are known to be present in mammalians, and that the
planarian nervous system constitutes particular neural networks and functions [15-19]. Since
planarians possess pluripotent stem cells throughout their entire bodies, their CNS can be
completely regenerated along with recovery of morphology and function after amputation [20].
Recently, two different processes of DA neuroregeneration in the planarian Dugesia japonica
have been described. One involves DA neuroregeneration accompanied by brain regeneration
after artificial amputation [15,21]. The other involves DA neuronal regeneration after selective
degeneration of DA neurons by the DA neurotoxin 6-hydroxydopamine (6-OHDA) [22].
Although both of these processes are achieved by manipulating pluripotent stem cells, the
systems of the processes are different between these regenerative processes [23]. In this section,
we focus on these two processes of DA neuroregeneration in planarians, one of prominent
regenerative animals.
2.1. Brain regeneration and DA neuroregeneration in planarians
Planarians can regenerate a functional brain within 7-10 days after amputation. This regener‐
ative process can be divided into at least five steps: (1) anterior blastema formation, (2) brain
rudiment formation, (3) pattern formation, (4) neural network formation and (5) functional
recovery. Each step is defined by sequential gene expression alterations that are similar to those
observed in mammalian brain development [20].
2.1.1. The early stage of brain regeneration after amputation
The first step of head regeneration after amputation is wound closure, which involves adhesion
of the dorsal and ventral tissues, thereby inducing activation of noggin-like gene A (DjnlgA) at
the edge of the amputated site [24]. Subsequently, a blastema (a mass of cells derived from
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pluripotent stem cells) is formed by mitogen-activated protein (MAP) kinase activation 24
hours after amputation [25,26]. It has been revealed that blastema cells are supplied from the
post-blastema region via mitosis from G2-phase pluripotent stem cells. Activation of c-Jun-N-
terminal kinase (JNK) after amputation induces G2/M transition and supplies blastema cells.
Subsequently, activation of extracellular signal-related kinase (ERK) signalling is required for
blastema cells to exit the undifferentiated state and enter the differentiation state in order to
form the brain rudiment [27]. Similarly, activation of ERK signalling facilitates exit from self-
renewal and regulates differentiation signals, as in mouse ESCs [28]. These findings indicate
that planarian stem cells and mouse ESCs may possess a similar molecular basis for cell fate
determination.
After the formation of the brain rudiment, the wnt and bone morphogenic protein (BMP)
signaling pathways regulate brain polarity along the anterior-posterior axis [29,30] and the
dorso-ventral axis [31,32], respectively. Therefore, pluripotent stem cells are regulated by
various signals in spacio and temporal manners to form the brain. Similarly, wnt and BMP
signaling pathways also regulate polarity of neural tube formation in mammalian early
development [33,34].
2.1.2. The stem cell system of DA neuroregeneration in the head regeneration process
During head regeneration, DA neurons begin to appear in future brain regions starting three
days after amputation. On day 5, the number of new DA neurons increases and axons start to
extend. On day 7, brain regeneration is complete along with complete reconstruction of DA
neurons (Figure 1A) [15]. Other neurotransmitter-synthesizing neurons, such as GABAergic,
octopaminergic (OA) and cholinergic neurons are also regenerated in a similar manner from
pluripotent stem cells during brain regeneration [17-19]. Recently, we revealed that the
numbers of each type of different brain neurons are maintained in a constant ratio that is
dependent on body size in intact planarians [21]. For instance, the ratio of DA neurons to OA
neurons is 2:1 in intact planarian brains. Interestingly, in the early stage of brain regeneration,
the ratio is larger than 2:1; however, it is gradually restored to 2:1 during brain regeneration.
The ratio among different neuronal cell types fluctuates in the early stages of regeneration and
is gradually restored to the original ratio. These data suggested that non-cell-autonomous
mechanisms utilized to adjust the ratio among different types of brain neurons [21].
2.2. DA neuronal regeneration after selective DA lesions
We recently established an experimental model to investigate cell-type specific regeneration
following selective degeneration by 6-hydroxydopamine (6-OHDA), a DA neurotoxin [22].
According to our observations, DA neurons are completely degenerated within 24 hours after 6-
OHDA-administration. Newly generated DA neurons begin to appear in the brain four days
after 6-OHDA-induced lesions. Thereafter, the number and the axons of DA neurons gradual‐
ly recover over a period of several days. Finally, DA neurons are completely recovered within
14 days after 6-OHDA-induced lesions (Figure 1B). Bromodeoxyuridine (BrdU)-pulse and chase
experiments indicate that newly generated DA neurons are derived from proliferative stem cells
that enter the S-phase in the trunk region and migrate to the head region from the trunk region
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without entering the M-phase (i.e., they remain in the G2-phase) and then give rise to DA neurons
in the head region (Figure 1C). In addition, histological analyses support the hypothesis that
pluripotent stem cells may directly give rise to differentiated DA neurons in planarians (Figure
1D, E). This observation suggests that G2-phase proliferating stem cells can respond to degener‐
ation of DA neurons and are committed to DA neurons in planarians [22].
Although most vertebrates show low regenerative capabilities, newts have powerful regen‐
erative abilities among adult vertebrates. Surprisingly, adult newts regenerate brain tissue
after partial brainectomy in spite of having a complex brain structure [35,36]. Recent reports
indicate that newts maintain the neurogenic potential to repair lost midbrain DA neurons,
even in the adult state [37]. Although proliferative abilities are essentially quiescent in the
midbrain of adult newts, quiescent ependymoglia cells are activated by the degeneration of
midbrain DA neurons. Additionally, activated ependymoglia cells start to proliferate and
differentiate to DA neurons to repair lost DA neurons. This neurogenic potential is activated
under conditions of injury-responsive cell-replacement and not under homeostatic conditions
[38,39]. These reports indicated that these regenerative animals possess unique stem cells
system to regenerative missing DA neurons.
3. Strategies for generation of DA neurons in non-regenerative animals
Regenerative animals easily regenerate lost brain and neural tissues by maturating stem cells.
Regenerative animals provide us unique ideas to generate neural tissue from mammalian
pluripotent stem cells such as ESCs and iPSCs.
Although the capacity for brain formation is present during the developmental stage among
animals, including human beings, it is difficult to regenerate missing neurons and brain tissue
in the adult state. It has been reported that neurogenesis homeostatically occurs in the restricted
regions of the adult mammalian brain such as hippocampus and subventricular zone [40,41].
However, it remains controversial whether dopaminergic neurogenesis/neuroregeneration
occurs in the adult mammalian midbrain [42,43] and whether neurogenic potential is “lost”
or “quiescent” in the adult mammalian brain. Regardless, this potential is not adequate to
recover missing neurons and brain tissue in the adult mammalian brain. If human beings had
an adequate regenerative potential, some types of neural disorders and brain injuries might
be self-curable. However, it is difficult to self-repair neurodegenerative disorders. Therefore,
it is strongly expected that neuronal differentiation techniques will contribute for therapeutic
applications, such as cell-transplantation therapy using ESCs/iPSCs.
Parkinson’s disease (PD) is a candidate disease for the expected application of cell-transplan‐
tation therapy. PD is an intractable neurodegenerative disorder that arises from the progres‐
sive death of DA neurons in the substantia nigra pars compacta. Although human beings lack
adequate abilities to regenerate DA neurons, techniques to generate midbrain DA neurons
from ESCs/iPSCs in vitro have been developed and are being improved for use in cell-
transplantation therapy (Figure 2).
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3.1. Induction of midbrain DA neurons in vitro from ESCs/iPSCs
In 2000, it was reported that stromal cell-derived inducing activity (SDIA) strongly promotes
neural induction in mouse ESCs co-cultured with mouse PA6 stromal cells under serum-free
conditions without growth factors [44]. SDIA-induced neurons contain high amounts of DA
neurons and are integrated into the 6-OHDA-lesioned mouse striatum after transplantation.
Additionally, it has been proven that functional DA neurons can be differentiated from primate
and human ESCs using SDIA [45,46]. Therefore, the establishment of the SDIA method opened
new fields for both basic neuroscience research and therapeutic applications.
Figure 1. A) The regeneration process of DA neurons after decapitation. Immunofluorescence of brain DA neurons
one day, three days, five days and seven days after decapitation. (B) The process of DA neuronal regeneration in the
brain after 6-OHDA-induced-lesions. Immunofluorescence of brain DA neurons in an intact brain three days, seven
days and 14 days after 6-OHDA-administration. (C) BrdU-incorporation is detected in newly generated DA neurons
five days after 6-OHDA-administration. Double-immunofluorescence of tyrosine hydroxylase (TH; green) and BrdU
(magenta). The arrowheads indicate BrdU/TH-double positive neurons. (D, E) Double-fluorescence of TH mRNA
(green) and PiwiA proteins (a marker for pluripotent stem cells; magenta) seven days after 6-OHDA-administration.
Scale bars: 200 µm (A-D), 50 µm (high magnification image in C) and 50 µm (E). (F) A schematic drawing of the pla‐
narian brain nervous system and an image of the distribution of DA neurons. The blue color represents the brain. The
orange color represents ventral nerve cords (VNCs). The green cells are DA neurons.
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Recently, the molecular mechanisms of mammalian brain development have become better
understood. The expression and secretion of patterning factors facilitate neural induction and
define anterior-posterior and dorso-ventral patterning of the mammalian brain. For instance,
mammalian midbrain development is governed by fibroblast growth factor 8 (FGF8) and Sonic
hedgehog (Shh), which are locally expressed at the midbrain-hindbrain boundary and the
ventral neural tube, respectively [47]. The floor plate is located along the ventral midline of
the neural tube and is known to function as a signaling center during brain development and
a source of midbrain DA neurons [48,49]. Midbrain DA neuronal specification is regulated by
several transcription factors, including Lmx1a, FoxA2, Nurr1 and Pitx3 [50-53]. Therefore,
cellular aspects of brain development provide ideas for improving the differentiation methods
of authentic neural identity and subtype specification, such as differentiating DA neurons from
ESCs/iPSCs in vitro.
Recently, neural lineage commitment has been improved with dual inhibition of SMAD
signaling by bone morphogenic protein (BMP) inhibitor (noggin and dorsomorphine) and
transforming growth factor-ß (TGF-ß)/activin/nodal inhibitor (SB431542). These combinations
promote efficient neural induction of both human ESCs and iPSCs in serum-free, floating
cultures of embryoid body-like aggregates (SFEB) and stromal (PA6) feeder co-cultures [54,55].
In addition, GSK3ß inhibitor (CHIR99021) strongly activates wnt signaling and induces the
Lmx1a expression in FoxA2-positive floor plate precursors and the neurogenic conversion of
human ESC-derived midbrain floor plates towards DA neurons [56]. This differentiation
method mimics mammalian brain development.
Recently, human ESCs/iPSCs maintenance and differentiation have been advanced in order to
achieve clinical translation, which results in chemically defined conditions and the elimination
of animal-derived components and the need for feeder cells [57,58].
Figure 2. A) A phase contrast image of colonies of undifferentiated human iPSCs on SNL feeder cells. (B) DA neurons
derived from human iPSCs differentiated using the SFEB method in vitro. Double-immunofluorescence of ßIII-tubulin
(TubßIII), a neuronal marker (green), and TH, a marker of DA neurons (magenta). Scale bars: 500 µm (A) and 50 µm
(B).
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4. Towards the clinical application of ESCs/iPSC-derived DA neurons in
Parkinson’s disease
Clinically, PD is estimated to affect approximately 1% of the population over 65 years of age,
and PD patients often exhibit muscle rigidity, tremors, bradykinesia and akinesia. Currently,
the primary clinical treatment for PD is dopamine replacement therapy using L-dihydroxy‐
phenylalanine (L-DOPA) and/or dopamine receptor agonists. Although pharmacotherapy
temporarily improves parkinsonian symptoms, the efficacy of pharmacotherapy is gradually
lost over long-term treatment, and the wearing-off phenomenon, the on-off phenomenon and
drug-induced dyskinesia develop. In addition, the progression of the degeneration of midbrain
DA neurons cannot be delayed. Therefore, new strategies such as cell transplantation therapy
are expected to recover lost DA neurons.
The first clinical trial of cell transplantation using human fetal ventral midbrain in PD patients
was performed in the latter half of the 1980’s [59]. Currently, over 400 PD patients have been
evaluated in this clinical trial. Some PD patients who underwent grafting have exhibited
drastic improvements in movement symptoms. However, strict ethical problems remain
regarding the use of human fetal cells for the treatment of human disease. Therefore, efficient
methods need to be developed for differentiating DA neurons from ESCs/iPSCs, instead of
using human fetal cells, as described above. In addition, the efficiency and safety of ESCs/
iPSCs-derived DA neurons should be evaluated in vivo experiments using animal models
before conducting human trials. In general, DA neurotoxins such as rotenone, 6-OHDA and
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are used to create parkinsonian animal
models with rodents and non-human primates. In particular, since the pathological symptoms
and brain anatomy of monkeys are similar to those of humans, the outcomes of monkey trials
strongly contribute to realizing human trials.
4.1. Preclinical trials of human ESCs/iPSC-derived DA neurons for PD
In 2005, it was reported that intra-striatal primate ESC-derived DA neurons survive and
function in the putamen in MPTP-lesioned primate parkinsonian models [60]. In that study,
positron emission tomography imaging revealed that [18F]-F-DOPA uptake increased in
grafted monkeys 14 weeks after transplantation. In addition, the neurological scores of the
grafted monkeys improved in comparison with that observed in sham-operated monkeys
starting from 10 weeks after transplantation. This study is the first report to indicate the
functional efficiency of grafted DA neurons derived from primate ESCs and has opened up
the possibility for transplantation therapy using ESC-derived DA neurons.
Meanwhile, human ESC/iPSC-derive DA neurons have the potential to improve motor
function in PD model rats after intra-striatal grafting [56,61,62]. However, some problems, such
as tumorigenicity, remain in clinical trials. We recently reported that long-term neural
maturation (> 28 days) of human ESCs reduces tumorigenicity after grafting in primate
parkinsonian models. In addition, motor symptoms are also improved by grafting human ESC-
derived DA neurons that have maturated over a long term (42 days). These results suggest
that human ESC-derived DA neurons that are differentiated for appropriate terms strongly
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contribute to both reducing the risk of tumor genesis and improving parkinsonian motor
dysfunction [46]. Recently, we first reported that human iPSC-derived DA neurons that are
differentiated under feeder-free and serum-free conditions survived in an MPTP-lesioned
primate parkinsonian model for six months [63]. This report may support the therapeutic
potential of human iPSCs for future clinical trials.
5. Stem cell utilization in vivo and in vitro for non-regenerative animals:
Lessons from regenerative animals
Although the number of regenerative animals used to investigate DA neuronal regenera‐
tion is  limited,  the  cellular  mechanisms of  DA neuronal  regeneration are  starting  to  be
understood [22,39]. The cellular and molecular mechanisms for DA neuronal regeneration
in regenerative animals provide new ideas for generation of DA neurons in non-regenera‐
tive animals. Our histological analysis of regeneration indicates that pluripotent stem cells
may directly give rise to differentiated DA neurons in the planarian head region (Figure
1D, E) [22]. In addition, we have not yet obtained direct evidence for the presence of neural
stem cells in planarians. First, we have not observed proliferating cells in the brain, either
during regeneration or  in  intact  brains.  Second,  the  expression of  the  planarian musashi
family  of  genes  supports  the  above  hypothesis.  Musashi,  an  RNA  binding  protein,  is
expressed in neural  stem cells  in various animals[64].  Although three musashi-like genes
(DjmlgA-C) have been isolated from planarians, the expressions of these genes are detect‐
ed in the planarian CNS and are not  eliminated by X-ray irradiation [65].  These results
indicate  that  planarian  musashi-like  genes  are  expressed  in  differentiated  cells,  not  in
proliferative stem cells. Based on these observations, we speculate that the neural stem cell
system most likely evolved at a later stage of evolution [66].
In the case of brain regeneration, the brain rudiment is formed inside of the blastema. The
cells that participate in blastema formation already exist from the proliferative state, and a
portion of these cells start to form the brain rudiment [25,26]. Therefore, the commitment
of DA neurons may immediately occur after brain rudiment and brain pattern formation.
In the case of DA neuronal regeneration after 6-OHDA-induced lesions, G2-phase stem cells
are recruited into DA neurons in the brain. Since the presence of neural stem cells were not
clarified in planarians, the key roles for differentiation into DA neurons from pluripotent stem
cells would function in G2-phase in the cell cycle. The neurons remaining in the brain after 6-
OHDA-induced lesions may play an important role in sensing the loss of DA neurons and
recruiting G2-phase stem cells into DA neurons [22]. Recent findings using eukaryote cells
indicate that cell fate determination of either self-renewal or differentiation occurs during the
G2/M phase in the cell cycle [67]. Therefore, the results of our study concerning the cellular
system of DA neuronal regeneration are supported by these observations. Therefore, G2-phase
stem cell strongly contributed to DA neuronal regeneration by response to extrinsic environ‐
ment in planarians. However, we have not yet understand a clear answer regarding which
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signal molecules contribute to the recruitment of G2-phase stem cells to DA neurons in
planarians.
In the case of newts, another regenerative animals, quiescent ependymoglia cells can sense
degeneration of DA neurons, and re-enter into the cell cycle to restore lost DA neurons [39].
In this case, DA receptor-expressing surrounding cells (i.e., ependymoglia cells) respond to the
degeneration of DA neurons via DA receptor signaling, and contribute to regenerate DA
neurons. Therefore, the responsibility of stem cells to extrinsic environment is important for
DA neuronal regeneration in both planarians and newts.
The findings from regenerative animals may provide any idea to generate DA neurons from
ESCs/iPSCs of non-regenerative animals. Recent strategies for DA neuronal induction from
ESCs/iPSCs have based on mimicking midbrain development, that is, the activation of
morphogenic factors and transcriptional regulation. In addition, the establishment of 3-
dimensional (3D) culture systems strongly contributes to mimicking the complicated organo‐
genesis and lead to the acquisition of sub-regional identities because the cells respond to
extrinsic signals [57, 69].
Recently, Kirkeby et al. developed an induction method for human ESC-derived DA neurons
using dual-SMAD inhibition with embryoid body formation. The gene expression profile and
transplantation aspects of human ESC-derived DA neurons can be recaptured in the human
fetal midbrain [70], suggesting that 3D cultures are suitable for mimicking brain organogenetic
processes in authentic midbrain DA neurons.
In  addition,  our  findings  in  planarians  may  contribute  to  improving  strategies  of  cell-
transplantation therapy. That is, how to integrate ESCs/iPSC-derived grafting neurons into
the host brain. We found that commitment to DA neurons in stem cells occurs during the
G2-phase of the cell cycle. Which state of committed cells can be easily incorporated into
lesioned regions and whether the location of commitment activates important factor(s) in
the  incorporation  of  committed  cells  into  appropriate  positions  should  be  considered.
Additionally, both planarians and newts showed drastic behavioral recovery according to
DA neuronal regeneration [22,37]. This suggested that regenerated DA neurons contribut‐
ed to functional recover by integrating to the existing neural circuit. We speculate that this
phenomenon may provide to the any ideas how to integrate ESCs/iPSC-derived neurons
into existing neural circuit after grafting and contribute to recover the motor function. We
will attempt to answer several important questions in our future works. A deeper under‐
standing of the answers to the above questions may provide unique clues regarding not
only how to commit DA neurons in vitro,  but also how to optimize cell-transplantation
therapy in the future.
6. Conclusion
Stem cell research is an interesting field in basic science due to its potential therapeutic
applications. It is now extensively studied to investigate that the cellular and molecular
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mechanisms of DA neuronal regeneration in many regenerative animals in vivo have been
described over the last several years, although numerous unclear issues remain. Important
aspects learned from regenerative animals suggest that the cell sources and stem cell systems
of DA neuronal regeneration may reflect several concepts in the achievement of regeneration,
even among regenerative animals. Therefore, it is difficult to find a common rule for DA
neuronal regeneration among animals. However, this trend in regenerative biology will be
more emphasized by discoveries made in future studies of regenerative animals, and will
provide hints about more efficient utilization of stem cells towards clinical application.
Importantly, studying the diversity of regenerative contexts in different animals may contrib‐
ute to highlighting diverse concepts and attractive clues for investigating the generation of DA
neurons in vivo and in vitro in regenerative medicine.
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